14 research outputs found
Diagnostic/prognostic value of cytological grading system by Robinson's method and morphometric objectification in determining gradus of invasive breast cancer
CILJ: Cilj istraživanja bio je uÄiniti citoloÅ”ko i morfometrijsko gradiranje citoloÅ”kih uzoraka invazivnog karcinoma dojke i prosuditi moguÄnost rutinske primjene citoloÅ”kog gradiranja s ili bez morfometrijske analize, umjesto dosadaÅ”nje procjene gradusa tumora na histoloÅ”kom materijalu; prosuditi reproducibilnost, konzistentnost i varijabilnost tehnike gradiranja meÄu citolozima; te opisati bioloÅ”ku varijabilnost morfometrijskih parametara unutar i izmeÄu gradusa, u svrhu optimalizacije i utvrÄivanja minimalne, trenutno nedefinirane, veliÄine uzorka potrebite za morfometrijsku analizu. ISPITANICI I METODE: Istraživanjem je obuhvaÄeno 45 ispitanica (15 po svakom gradusu) u kojih je dijagnoza karcinoma dojke postavljena na citoloÅ”kim aspiratima dojke u OB āDr. J. BenÄeviÄā tijekom 2012. godine. CitoloÅ”ko gradiranje uÄinjeno je Robinsonovom metodom gradiranja, a odreÄivanje histoloÅ”kog gradusa koriÅ”tenjem Elstonove modifikacije Bloom-Richardson-ove metode. Morfometrijska analiza provedena je programom SFORM. REZULTATI: Slaganje tri promatraÄa u odreÄivanju citoloÅ”kog gradusa i njegovoj komparaciji s histoloÅ”kim gradusom procijenjeno je Kendall T-B testom. T vrijednosti iznosile su od 0,64 do 0,82. T vrijednosti izmeÄu promatraÄa uzetog kao standard (promatraÄ s najveÄim volumenom pregledanih uzoraka karcinoma dojke) i druga dva promatraÄa (interobserver varijabilnost) iznosile su od 0,45 do 0,85. Slaganje pojedinog promatraÄa pri ponovljenom citoloÅ”kom gradiranju (intraobserver varijabilnost) iznosilo je od 0,57 do 0,79. DijagnostiÄka/prognostiÄka vrijednost citoloÅ”kog sustava gradiranja po Robinsonu i morfometrijska objektivizacija u odreÄivanju gradusa invazivnog karcinoma dojke 81 SAŽETAK S porastom gradusa uoÄava se pad ekspresije progesteronskih receptora, znaÄajan, stupnjeviti porast ekspresije proliferacijskog biljega Ki-67, viÅ”i pT stadij, te veÄi udio postmenopauzalnih ispitanica. Analizom razlika u distribuciji morfometrijskih parametara po gradusu izdvaja se znaÄajan, stupnjevit porast mjerenih znaÄajki s porastom gradusa. Gradus je odgovoran za prosjeÄno tek 26, odnosno 35% varijance morfometrijskih obilježja stanice i jezgre. Glavninu varijance obilježja Äine interindividualne razlike, odnosno heterogenosti meÄu ispitanicima unutar gradusa, uz minimalne intraindividualne varijacije. Minimalnu, trenutno nedefiniranu, veliÄinu uzorka potrebitu za morfometrijsku analizu normirali smo na 100 stanica po uzorku, buduÄi da ista jamÄi usku marginu greÅ”ke. ZAKLJUÄAK: CitoloÅ”ko gradiranje aspirata karcinoma dojke reproducibilno je i neovisno o iskustvu morfologa te dobro korelira s histoloÅ”kim gradusom. PosljediÄno tome predstavlja koristan parametar u predviÄanju histoloÅ”kog gradusa, odnosno bioloÅ”kog ponaÅ”anja tumora. Gradiranje morfometrijskom metodom statistiÄki je znaÄajno, ali zbog niskog udjela gradusa u varijanci morfometrijskih obilježja, odnosno Å”irokog raspona preklapanja morfometrijskih parametara meÄu gradusima, morfometrija kao metoda nema diskriminacijsku nego samo indikativnu sposobnost.AIM: The aim of this study was to evaluate the cytological and morphometrical grading of breast cancer and to estimate the possibility of routine use of cytologic grading with or without morphometric analysis, instead of estimating the tumor grade only on histologic material; to estimate reproducibility, consistency and variability of grading techniques among cytologists and also to describe the biological variability of morphometric parameters within and between grades and to determine the minimum, currently undefined, of sample size required for morphometric analysis. MATERIAL AND METHODS: Forty five patients with histologically confirmed invasive breast carcinoma, treated in General Hospital Dr. J. Bencevic in 2012, were selected in the present study. Grading of breast carcinoma was done according to the Robinsonās method by three independent observers on two occasions. Histological grading was performed using Elston's modified Bloom Richardsons' scoring. Morphometric analysis was performed by means of the SFORM software. RESULTS: The agreement between observers in determining the cytological grade and it's comparison with histological grade was estimated with Kendall T-B test. T values ranged from 0.64 to 0.82. T values between standard observer (the one with highest volume of examined breast specimens) and the other two observers (interobserver varability) ranged from 0.45 to 0.85 for cytological grading. Agreement between the individual observer at the repeated cytological grading (intraobserver variability) ranged from 0.57 to 0.79. DijagnostiÄka/prognostiÄka vrijednost citoloÅ”kog sustava gradiranja po Robinsonu i morfometrijska objektivizacija u odreÄivanju gradusa invazivnog karcinoma dojke 83 SUMMARY With increasing tumor grade we observed the decrease of progesterone receptors expression , significant increase in the expression of the proliferation marker Ki-67, higher pT stage, and large proportion of postmenopausal women. By analyzing differences in the distribution of morphometric parameters by grade we observed a significant, gradual increase in the measured characteristics with increasing grade. Gradus is responsible for an average of 26 or 35% of the variance of morphometric characteristics of cells and nuclei. The majority of the variance features make interindividual differences or heterogeneity among respondents within the grade. Minimal sample size which is currently undefined and not standardized and was needed for morphometric analysis, was normalized to 100 cells per sample, since the same guarantees a narrow margin of error. CONCLUSION: Cytological grading of aspirates of breast cancer is reproducible and independent of experience of morphologist and correlates well with established histological grade and as such can be predictor of histologic grade and provide relevant information about the biological behavior of invasive breast cancer. Morphometric grading method is statistically significant but due to low proportion of grade in variance of morphometric features and a wide range of overlapping morphometric parameters among grades differences, morphometry as a method does not have discriminatory but just indicative capacity
Pap Test ā With or Without Vaginal Smear?
The aim of this study was to evaluate medical and economic justification of vaginal smears as a part of primary screening for cervical carcinoma and its precursors. Study included 245.048 participants whose VCE (vaginal, cervical, endocervical) smears were examined at Department of clinical cytology of University Hospital Center Osijek from 2003 till 2008. There were 12.639 (5.2%) abnormal findings, and they were divided into three groups: abnormal cells found only in vaginal smear (V), abnormal cells found in vaginal and in at least one other smear (V+) and abnormal cells not found in vaginal smear (C/E). These three groups were analysed in respect to cytological differential diagnosis and age of participants. It was estimated how many women could be additionally included in the screening, if vaginal smear would be included in the Pap test only after 50 years of age. In 6.9% of cytologically diagnosed lesions abnormal cells were found exclusively in vaginal smears (0.35% of all findings). As for squamous cell lesions, 91.2% were mild lesions (ASC and LSIL). Invasive squamous cell carcinoma was not diagnosed exclusively by vaginal smear in either woman under 50 years of age, while in women over 50 years of age it was diagnosed in 2.3% of cases. Exclusively by vaginal smear was diagnosed 3.9% of all AGC and 6.3% of adenocarcinoma, while in 85.0% of glandular epithelium lesions abnormal cells were not found in vaginal smears. Two thirds of adenocarcinoma diagnosed exclusively by vaginal smears were endometrial adenocarcinoma, but that is only 10.3% of all endometrial carcinoma diagnosed by Pap test. Obtained results show that taking of vaginal smears along with cervical and endocervical smears as a part of primary screening for cervical carcinoma and its precursors in women under 50 years of age is not justifiable, since vaginal smear only has a role in detection of endometrial carcinoma that are extremely rare in younger age groups. If vaginal smear would be taken only in women over 50 years of age, additional 37.7% of women under 50, or 25.1% women over 50 years of age could be included in the screening
Morphometry of Tumor Cells in Different Grades and Types of Breast Cancer
The aim of the study was to compare morphometric characteristics of different types and grades of breast cancer. Morphometric analysis was performed using the SFORM software (Vamstec, Zagreb) on the May-GrĆ¼nwald-Giemsa stained fine needle aspiration cytology (FNAC) breast tissue specimens. The study included 42 patients diagnosed with breast carcinoma by breast smear FNAC at Merkur University Hospital during the 2001ā2005 period. Postoperative tumor histopathology and semi-quantitative tumor grading by the method of Elston and Ellis1 showed invasive ductal carcinoma grade I in 10, invasive ductal carcinoma grade II in 9, invasive ductal carcinoma grade III in 13, and invasive lobular carcinoma in 13 patients, the latter also including a subtype of invasive tubulolobular carcinoma. The following parameters were assessed by use of Statistica 7.1 and c2-test: tumor area, circumference, maximal radius, minimal radius, convexity, length, width, elongation, nucleus/cytoplasm ratio, and shape factor. Morphometric analysis yielded statistically significant differences among all study groups (p<0.001). Morphometric parameters showed significant individual correlation with tumor type and grade, whereby the area, convexity and circumference were most significant at both nuclear and cellular level
Diagnostic/prognostic value of cytological grading system by Robinson's method and morphometric objectification in determining gradus of invasive breast cancer
CILJ: Cilj istraživanja bio je uÄiniti citoloÅ”ko i morfometrijsko gradiranje citoloÅ”kih uzoraka invazivnog karcinoma dojke i prosuditi moguÄnost rutinske primjene citoloÅ”kog gradiranja s ili bez morfometrijske analize, umjesto dosadaÅ”nje procjene gradusa tumora na histoloÅ”kom materijalu; prosuditi reproducibilnost, konzistentnost i varijabilnost tehnike gradiranja meÄu citolozima; te opisati bioloÅ”ku varijabilnost morfometrijskih parametara unutar i izmeÄu gradusa, u svrhu optimalizacije i utvrÄivanja minimalne, trenutno nedefinirane, veliÄine uzorka potrebite za morfometrijsku analizu. ISPITANICI I METODE: Istraživanjem je obuhvaÄeno 45 ispitanica (15 po svakom gradusu) u kojih je dijagnoza karcinoma dojke postavljena na citoloÅ”kim aspiratima dojke u OB āDr. J. BenÄeviÄā tijekom 2012. godine. CitoloÅ”ko gradiranje uÄinjeno je Robinsonovom metodom gradiranja, a odreÄivanje histoloÅ”kog gradusa koriÅ”tenjem Elstonove modifikacije Bloom-Richardson-ove metode. Morfometrijska analiza provedena je programom SFORM. REZULTATI: Slaganje tri promatraÄa u odreÄivanju citoloÅ”kog gradusa i njegovoj komparaciji s histoloÅ”kim gradusom procijenjeno je Kendall T-B testom. T vrijednosti iznosile su od 0,64 do 0,82. T vrijednosti izmeÄu promatraÄa uzetog kao standard (promatraÄ s najveÄim volumenom pregledanih uzoraka karcinoma dojke) i druga dva promatraÄa (interobserver varijabilnost) iznosile su od 0,45 do 0,85. Slaganje pojedinog promatraÄa pri ponovljenom citoloÅ”kom gradiranju (intraobserver varijabilnost) iznosilo je od 0,57 do 0,79. DijagnostiÄka/prognostiÄka vrijednost citoloÅ”kog sustava gradiranja po Robinsonu i morfometrijska objektivizacija u odreÄivanju gradusa invazivnog karcinoma dojke 81 SAŽETAK S porastom gradusa uoÄava se pad ekspresije progesteronskih receptora, znaÄajan, stupnjeviti porast ekspresije proliferacijskog biljega Ki-67, viÅ”i pT stadij, te veÄi udio postmenopauzalnih ispitanica. Analizom razlika u distribuciji morfometrijskih parametara po gradusu izdvaja se znaÄajan, stupnjevit porast mjerenih znaÄajki s porastom gradusa. Gradus je odgovoran za prosjeÄno tek 26, odnosno 35% varijance morfometrijskih obilježja stanice i jezgre. Glavninu varijance obilježja Äine interindividualne razlike, odnosno heterogenosti meÄu ispitanicima unutar gradusa, uz minimalne intraindividualne varijacije. Minimalnu, trenutno nedefiniranu, veliÄinu uzorka potrebitu za morfometrijsku analizu normirali smo na 100 stanica po uzorku, buduÄi da ista jamÄi usku marginu greÅ”ke. ZAKLJUÄAK: CitoloÅ”ko gradiranje aspirata karcinoma dojke reproducibilno je i neovisno o iskustvu morfologa te dobro korelira s histoloÅ”kim gradusom. PosljediÄno tome predstavlja koristan parametar u predviÄanju histoloÅ”kog gradusa, odnosno bioloÅ”kog ponaÅ”anja tumora. Gradiranje morfometrijskom metodom statistiÄki je znaÄajno, ali zbog niskog udjela gradusa u varijanci morfometrijskih obilježja, odnosno Å”irokog raspona preklapanja morfometrijskih parametara meÄu gradusima, morfometrija kao metoda nema diskriminacijsku nego samo indikativnu sposobnost.AIM: The aim of this study was to evaluate the cytological and morphometrical grading of breast cancer and to estimate the possibility of routine use of cytologic grading with or without morphometric analysis, instead of estimating the tumor grade only on histologic material; to estimate reproducibility, consistency and variability of grading techniques among cytologists and also to describe the biological variability of morphometric parameters within and between grades and to determine the minimum, currently undefined, of sample size required for morphometric analysis. MATERIAL AND METHODS: Forty five patients with histologically confirmed invasive breast carcinoma, treated in General Hospital Dr. J. Bencevic in 2012, were selected in the present study. Grading of breast carcinoma was done according to the Robinsonās method by three independent observers on two occasions. Histological grading was performed using Elston's modified Bloom Richardsons' scoring. Morphometric analysis was performed by means of the SFORM software. RESULTS: The agreement between observers in determining the cytological grade and it's comparison with histological grade was estimated with Kendall T-B test. T values ranged from 0.64 to 0.82. T values between standard observer (the one with highest volume of examined breast specimens) and the other two observers (interobserver varability) ranged from 0.45 to 0.85 for cytological grading. Agreement between the individual observer at the repeated cytological grading (intraobserver variability) ranged from 0.57 to 0.79. DijagnostiÄka/prognostiÄka vrijednost citoloÅ”kog sustava gradiranja po Robinsonu i morfometrijska objektivizacija u odreÄivanju gradusa invazivnog karcinoma dojke 83 SUMMARY With increasing tumor grade we observed the decrease of progesterone receptors expression , significant increase in the expression of the proliferation marker Ki-67, higher pT stage, and large proportion of postmenopausal women. By analyzing differences in the distribution of morphometric parameters by grade we observed a significant, gradual increase in the measured characteristics with increasing grade. Gradus is responsible for an average of 26 or 35% of the variance of morphometric characteristics of cells and nuclei. The majority of the variance features make interindividual differences or heterogeneity among respondents within the grade. Minimal sample size which is currently undefined and not standardized and was needed for morphometric analysis, was normalized to 100 cells per sample, since the same guarantees a narrow margin of error. CONCLUSION: Cytological grading of aspirates of breast cancer is reproducible and independent of experience of morphologist and correlates well with established histological grade and as such can be predictor of histologic grade and provide relevant information about the biological behavior of invasive breast cancer. Morphometric grading method is statistically significant but due to low proportion of grade in variance of morphometric features and a wide range of overlapping morphometric parameters among grades differences, morphometry as a method does not have discriminatory but just indicative capacity
Morphometry of tumor cells in different grades and types of breast cancer [Morfometrija tumorskih stanica kod razliÄitih gradusa i tipova karcinoma dojke]
The aim of the study was to compare morphometric characteristics of different types and grades of breast cancer. Morphometric analysis was performed using the SFORM software (Vamstec, Zagreb) on the May-GrĆ¼nwald-Giemsa stained fine needle aspiration cytology (FNAC) breast tissue specimens. The study included 42 patients diagnosed with breast carcinoma by breast smear FNAC at Merkur University Hospital during the 2001ā2005 period. Postoperative tumor histopathology and semi-quantitative tumor grading by the method of Elston and Ellis1 showed invasive ductal carcinoma grade I in 10, invasive ductal carcinoma grade II in 9, invasive ductal carcinoma grade III in 13, and invasive lobular carcinoma in 13 patients, the latter also including a subtype of invasive tubulolobular carcinoma. The following parameters were assessed by use of Statistica 7.1 and c 2-test: tumor area, circumference, maximal radius, minimal radius, convexity, length, width, elongation, nucleus/cytoplasm ratio, and shape factor. Morphometric analysis yielded statistically significant differences among all study groups (p<0.001). Morphometric parameters showed significant individual correlation with tumor type and grade, whereby the area, convexity and circumference were most significant at both nuclear and cellular level
Papa test - Sa ili bez vaginalnog razmaza?
The aim of this study was to evaluate medical and economic justification of vaginal smears as a part of primary screening for cervical carcinoma and its precursors. Study included 245.048 participants whose VCE (vaginal, cervical, endocervical) smears were examined at Department of clinical cytology of University Hospital Center Osijek from 2003 till 2008. There were 12.639 (5.2%) abnormal findings, and they were divided into three groups: abnormal cells found only in vaginal smear (V), abnormal cells found in vaginal and in at least one other smear (V+) and abnormal cells not found in vaginal smear (C/E). These three groups were analysed in respect to cytological differential diagnosis and age of participants. It was estimated how many women could be additionally included in the screening, if vaginal smear would be included in the Pap test only after 50 years of age. In 6.9% of cytologically diagnosed lesions abnormal cells were found exclusively in vaginal smears (0.35% of all findings). As for squamous cell lesions, 91.2% were mild lesions (ASC and LSIL). Invasive squamous cell carcinoma was not diagnosed exclusively by vaginal smear in either woman under 50 years of age, while in women over 50 years of age it was diagnosed in 2.3% of cases. Exclusively by vaginal smear was diagnosed 3.9% of all AGC and 6.3% of adenocarcinoma, while in 85.0% of glandular epithelium lesions abnormal cells were not found in vaginal smears. Two thirds of adenocarcinoma diagnosed exclusively by vaginal smears were endometrial adenocarcinoma, but that is only 10.3% of all endometrial carcinoma diagnosed by Pap test. Obtained results show that taking of vaginal smears along with cervical and endocervical smears as a part of primary screening for cervical carcinoma and its precursors in women under 50 years of age is not justifiable, since vaginal smear only has a role in detection of endometrial carcinoma that are extremely rare in younger age groups. If vaginal smear would be taken only in women over 50 years of age, additional 37.7% of women under 50, or 25.1% women over 50 years of age could be included in the screening.Cilj ove studije bio je procijeniti medicinsku i ekonomsku opravdanost uzimanja vaginalnog razmaza u sklopu primarnog probira cervikalnog karcinoma i njegovih prekursora. U studiju je ukljuÄeno 245.408 ispitanica Äiji su VCE (vaginalni, cervikalni, endocervikalni) razmazi bili pregledani na Odjelu za kliniÄku citologiju KliniÄkog bolniÄkog centra Osijek od 2003. do 2008. godine. Abnormalnih je nalaza bilo 12.639 (5,2%), a podijeljeni su u tri skupine: abnormalne stanice naÄene samo u vaginalnom razmazu (V), abnormalne stanice naÄene u vaginalnom i bar u joÅ” jednom razmazu (V+) i abnormalne stanice nisu naÄene u vaginalnom razmazu (C/E). Te su tri skupine analizirane u odnosu na citoloÅ”ku diferencijalnu dijagnozu i životnu dob ispitanica. Procijenjeno je koliko bi se `ena moglo dodatno obuhvatiti probirom ukoliko bi se vaginalni razmaz ukljuÄio u PAPA test tek nakon pedesete godine života. U 6,9% citoloÅ”ki dijagnosticiranih lezija abnormalne su stanice naÄene iskljuÄivo u vaginalnim razmazima (0,35% svih nalaza). Kod lezija ploÄastog epitela u 91,2% sluÄajeva radilo se o lakÅ”im lezijama (ASC i LSIL). Invazivni ploÄasti karcinom iskljuÄivo vaginalnim razmazom nije dijagnosticiran niti u jedne žene mlaÄe od 50 godina, dok je u žena starijih od 50 godina dijagnosticiran u 2,3% sluÄajeva. IskljuÄivo vaginalnim razmazom otkriveno je 3,9% svih AGC i 6,3% adenokarcinoma, dok kod 85,0% lezija žljezdanog epitela abnormalne stanice nisu naÄene u vaginalnim razmazima. Dvije treÄine adenokarcinoma dijagnosticiranih iskljuÄivo vaginalnim razmazom Äini adenokarcinom endometrija, no to je samo 10,3% svih PAPA testom dijagnosticiranih endometralnih karcinoma. Iz navedenih se rezultata može zakljuÄiti da Äenama mlaÄim od pedeset godina nema opravdanja uz cervikalni i endocervikalni uzeti i vaginalni razmaz u sklopu primarnog probira cervikalnog karcinoma i njegovih prekursora, buduÄi da vaginalni razmaz ima ulogu jedino u detekciji endometralnih karcinoma koji su u mlaÄim dobnim skupinama izuzetno rijetki. Ukoliko bi se vaginalni razmaz uzimao samo ženama starijim od 50 godina moglo bi se dodatno pregledati joÅ” 37,7% žena mlaÄih od 50 godina, ili 25,1% žena starijih od 50 godina
Value of Cytology in Small Cell Lung Carcinoma Diagnostic ā Single-Center Study
Small cell carcinoma of the lung (SCLC) together with the large cell neuroendocrine carcinoma (LCNEC), typical carcinoid (TC), and atypical carcinoid (AC) make a group of morphologically identifiable neuroendocrine tumors. The differential diagnosis of SCLC includes, first of all, other neuroendocrine tumors, and primary or metastatic non-small cell carcinomas. Although the criteria for the morphologic separation from other tumors of the lung are defined, in everyday practice it can be a problem, both in cytology and with histological samples. Accurate and early differentiation of the SCLC is important because it exhibits aggressive behavior, rapid growth, early spread to distant sites, but also exquisite sensitivity to chemotherapy and radiation. The study included 127 patients who underwent bronchoscopic examination or percutaneous transthoracic fine-needle aspiration (PTTFNA) during the period from early 2003 to 2007 in University Hospital Center Osijek whose cytological diagnosis was SCLC. The value of cytological diagnosis was determined by comparing it with histological findings obtained from a biopsy sample during bronchoscopy or on a resection specimen in 50 patients. In the remaining 77 patients, histological verification of cytological diagnosis was not made and the patients were treated based on cytological diagnosis of small cell carcinoma. In 76% of cases (38/50) cytological diagnosis of small cell lung carcinoma was also confirmed histologically.Ā In 8% of cases (4/50) adenocarcinoma was histologically confirmed, in 10% (5/50) of the cases the squamous carcinoma was confirmed, and there was one case of urothelial carcinoma, one case of sarcoma and one undifferentiated carcinoma.Ā Cytological diagnosis of SCLC was made in all cases in a brush smear while the catheter aspirate was positive in only 32 cases (25,8%). Median survival in the group of patients with histologically confirmed small cell cancer was 238 days, for women 250 days, and for men 237 days. Cumulative survival was 63,2% for 6 months, 26,3% for 12 months, 13,2% for 18 months and 7,9% for two years. In conclusion, cytology is a reliable and relatively non-invasive method for patients. Our results confirm that there is a good correlation between cytology and histology diagnoses, especially when it comes to malignant lesions. In determining the type of tumor cytology must be supported with additional methods, especially in cases when it is not possible to take samples for histological verification
Citodijagnostika karcinoma malih stanica pluÄa
Small cell carcinoma of the lung (SCLC) together with the large cell neuroendocrine carcinoma (LCNEC), typical carcinoid (TC), and atypical carcinoid (AC) make a group of morphologically identifiable neuroendocrine tumors. The differential diagnosis of SCLC includes, first of all, other neuroendocrine tumors, and primary or metastatic non-small cell carcinomas. Although the criteria for the morphologic separation from other tumors of the lung are defined, in everyday practice it can be a problem, both in cytology and with histological samples. Accurate and early differentiation of the SCLC is important because it exhibits aggressive behavior, rapid growth, early spread to distant sites, but also exquisite sensitivity to chemotherapy and radiation. The study included 127 patients who underwent bronchoscopic examination or percutaneous transthoracic fine-needle aspiration (PTTFNA) during the period from early 2003 to 2007 in University Hospital Center Osijek whose cytological diagnosis was SCLC. The value of cytological diagnosis was determined by comparing it with histological findings obtained from a biopsy sample during bronchoscopy or on a resection specimen in 50 patients. In the remaining 77 patients, histological verification of cytological diagnosis was not made and the patients were treated based on cytological diagnosis of small cell carcinoma. In 76% of cases (38/50) cytological diagnosis of small cell lung carcinoma was also confirmed histologically. In 8% of cases (4/50) adenocarcinoma was histologically confirmed, in 10% (5/50) of the cases the squamous carcinoma was confirmed, and there was one case of urothelial carcinoma, one case of sarcoma and one undifferentiated carcinoma. Cytological diagnosis of SCLC was made in all cases in a brush smear while the catheter aspirate was positive in only 32 cases (25,8%). Median survival in the group of patients with histologically confirmed small cell cancer was 238 days, for women 250 days, and for men 237 days. Cumulative survival was 63,2% for 6 months, 26,3% for 12 months, 13,2% for 18 months and 7,9% for two years. In conclusion, cytology is a reliable and relatively non-invasive method for patients. Our results confirm that there is a good correlation between cytology and histology diagnoses, especially when it comes to malignant lesions. In determining the type of tumor cytology must be supported with additional methods, especially in cases when it is not possible to take samples for histological verification.Karcinom malih stanica pluÄa (SCLC) klasificira se u skupinu neuroendokrinih tumora pluÄa. Iako su kriteriji za njegovo morfoloÅ”ko odjeljivanje od ostalih tumora pluÄa dobro definirani, u praksi to može predstavljati problem, kako u citologiji tako i na histoloÅ”kim uzorcima. Važnost toÄnog i ranog diferenciranja karcinoma malih stanica leži u njegovom agresivnom ponaÅ”anju, rapidnom rastu i stvaranju udaljenih metastaza, ali jednako tako i njegovoj osjetljivosti na kemoterapiju i zraÄenje. U studiju je ukljuÄeno 127 pacijenata kojima je u razdoblju od poÄetka 2003. do kraja 2007. godine uÄinjen bronhoskopski pregled ili transtorakalna punkcija te je citoloÅ”ka dijagnoza bila karcinom malih stanica. Vrijednost citoloÅ”ke dijagnoze karcinoma malih stanica utvrÄena je usporedbom s histoloÅ”kom dijagnozom donesenom na bioptiÄkom ili resekcijskom materijalu. U 76% sluÄajeva (38/50) citoloÅ”ka dijagnoza SCLC je potvrÄena i histoloÅ”ki. U 8% sluÄajeva (4/50) histoloÅ”ki je potvrÄen adenokarcinom, 10% sluÄajeva (5/50) ploÄasti karcinom, a u po jednom sluÄaju metastaza karcinoma prijelaznih stanica i sarkoma te nediferencirani karcinom. U ostalih 77 pacijenata (77/ 127; 60,6%) nije uÄinjena patohistoloÅ”ka verifikacija te su oni lijeÄeni u skladu s kliniÄkom prosudbom i citoloÅ”kom dijagnozom SCLC. CitoloÅ”ka dijagnoza SCLC postavljena je kod svih sluÄajeva na brisu Äetkicom dok je kateter aspirat bio pozitivan samo u 32 sluÄaja (26%). ProsjeÄno preživljenje pacijenata od prve citoloÅ”ke dijagnoze u grupi pacijenata s histoloÅ”ki potvrÄenim SCLC iznosilo je 238 dana, za žene prosjeÄno 250 dana, a za muÅ”karce prosjeÄno 237 dana. ZakljuÄno, citologija je jednako vrijedna metoda kao i histologija u odreÄivanju prisustva maligne bolesti, ali u odreÄivanju tipa tumora potrebno ju je nadopuniti dodatnim metodama, prije svega imunocitokemijom, osobito u sluÄajevima kada nije moguÄe dobiti histoloÅ”ki uzorak
Diagnostic Value of Cytology of Voided Urine
There are 961 new cases and approximately 366 deaths from urothelial carcinoma registered annually in Croatia. Exfoliative urinary cytology has important role in detection of high grade urinary tumors, invasive and in situ lesions respectively. In contrast to cystoscopy and biopsy, cytology is a noninvasive method which is easily repeated. The aim of this retrospective study was to assess value of urinary cytology in our institution. For this purpose only patients with histological diagnosis and clinical follow up were considered. There were 138 urine specimens with cytological diagnosis of dyskaryosis, suspicious for malignancy or malignant and histology and follow up data examined at our Department of Clinical Cytology between 2004 and 2011. Cytological diagnosis suspicious for malignancy and malignant were considered positive and the results were correlated with histological diagnosis according to the WHO histological classification of tumors of the urinary tract. Patients with negative histological findings were followed for the next two years. The positive predictive value of cytological detection of malignant urothelial lesions was 91.8%. In 10 cases cytological diagnosis of malignancy was not confirmed histologically or clinically which makes the total of 8.2% of false positive reports. Of the total of detected malignant urothelial lesions 90.9% are high grade lesions and only 9.1% low-grade lesions; 67.3% are invasive lesions and 32.7% non-invasive lesions. Cytological findings of dyskariotyc cells requires further urological investigation because such findings in further processing prove the presence of tumor in 93.8% of cases. In conclusion: cytology is very good diagnostic tool for detection of high grade invasive and noninvasive carcinomas of the urinary tract. In order to make it more efficient we need to study its limits carefully, define diagnostic criteria and reach consensus in nomenclature
Hepatocellular carcinoma and impact of aflatoxin difuranocoumarin derivative system: A case report
Introduction. Hepatocellular carcinoma (HCC) is the most frequent type of
liver malignancy. As a carcinogen, aflatoxin B1 (AFB1) causes HCC by inducing
deoxyribonucleic acid adducts that lead to genetic changes in liver cells and
may be the cause of HCC in up to 30% of cases. The incidence of HCC has been
on the rise and is an issue in the countries of the Western Balkans. Case
Outline. This paper presents a case of a 37-year-old woman who was diagnosed
with HCC, without hepatitis B, hepatitis C, or liver cirrhosis. The patient
consumed milk and dairy products in quantities of over two liters per day
over the course of 20 years, which indicates the impact of aflatoxin in milk
on HCC. A positive signal for the presence of AFB1 was detected by ELISA
(enzyme-linked immunosorbent assay) in-house using immunoperoxidase screening
test. Conclusion. As carcinogenic difuranocoumarin derivative, aflatoxin B1
is the most likely cause of malignant transformation of hepatocytes, which
resulted in hepatocellular carcinoma in this patient